Appeal No. 1996-2209
Application No. 08/031,346
Edelson 4,684,521 Aug. 4, 1987
Wiesehahn 4,748,120 May 31, 1988
German Patent Application
Kief (DT’91) 3,109,691 Sep. 23, 1982
OPINION
In reaching our decision in this appeal, we have given careful consideration to the
appellant’s specification and claims, to the applied prior art references, and to the respective
positions articulated by the appellant and the examiner.
Rather than reiterate the conflicting viewpoints advanced by the examiner and the
appellant regarding the noted rejections, we make reference to the examiner's Answer for the
examiner's reasoning in support of the rejection, and to the appellant’s Brief for the appellant’s
arguments thereagainst. As a consequence of our review, we make the determinations which
follow.
Background
The claimed invention is directed to a process of production of a germicidally treated
suspension which is useful for the treatment of illnesses such as atopic neurodermatitis,
bronchial asthma, nasal allergies, allergies, colitis ulcerosa, Parkinson, Morbus Crohn,
hepatitis, chronic hepatitis, chronic sinusitis, psoriasis, rheumatic-type indications,
carcinomas, multiple sclerosis and scleroderma Sjögren syndrome. The process of
4
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: November 3, 2007